Dendreon Corp fka DNDNQ

[hondaboost]

Valeant Pharmaceuticals (VRX - Get Report) announced late Thursday a tentative deal to acquire the assets of Dendreon -- mostly its prostate-cancer vaccine Provenge and manufacturing facilities -- for $296 million in cash.

Dendreon filed for Chapter 11 bankruptcy protection in November because Provenge sales of around $300 million annually were not sufficient to generate profits or repay $620 million in convertible debt due next year. The bankruptcy wiped out Dendreon's equity shareholders. If the Valeant deal goes through, even Dendreon's creditors will be only partially repaid.
The Commons will get Zero and be Wiped OUT !

http://www.thestreet.com/story/13029038/1/dendreons-asset-rummage-sale-completes-the-circle-of-life.html?puc=yahoo&cm_ven=YAHOO